Pacific Biosciences Of California (PACB) Other Operating Expenses (2015 - 2026)

Pacific Biosciences Of California has reported Other Operating Expenses for 8 years, with the latest figure at $45.8 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses changed N/A year-over-year to $45.8 million; the trailing twelve-month figure through Mar 2026 stood at $40.4 million (down 78.22% YoY), and the FY2025 full-year result was $347.9 million, up 85.14% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $45.8 million, up from -$1.9 million in the prior quarter.
• The five-year high for Other Operating Expenses was $93.9 million in Q2 2024, with the low at -$7.8 million in Q2 2022.
• Average Other Operating Expenses over 5 years is $14.4 million, with a median of $1.3 million recorded in 2022.
• Year-over-year, Other Operating Expenses surged 11098.01% in 2024 and tumbled 360.06% in 2025.
• Tracing PACB's Other Operating Expenses over 5 years: stood at $2.1 million in 2022, then jumped by 72.26% to $3.5 million in 2023, then soared by 2474.49% to $91.1 million in 2024, then tumbled by 102.09% to -$1.9 million in 2025, then soared by 2506.52% to $45.8 million in 2026.
• The last three Other Operating Expenses figures came in at $45.8 million (Q1 2026), -$1.9 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.

Peer Comparison